A Study to Evaluate the Safety and Efficacy of JZP926 Capsule for the Treatment of Juvenile Myoclonic Epilepsy
Clinical trial NCT07723963 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07723963
- Sponsor
- Jazz Pharmaceuticals
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-09-01
- Primary completion
- 2028-08-01
- Enrollment
- 260
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.